This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Joe Guiles, PhD
Head of Chemical Development at Agilent Technologies
Speaker

Profile

Joe is a Pharma/Biotech senior leader with extensive experience in building and leading technical functions that focus on clinical and commercial stage therapeutic API’s. He is currently the Head of Development at Agilent Technologies Nucleic Acid Solution Division in Boulder, CO. His past employers included Medivation, Cedarburg-Hauser, Replidyne, Sanofi-Aventis, and Johnson & Johnson.

Agenda Sessions

  • Important Aspects to Successful Manufacturing Outcomes Through Agilent’s Six Years of Making GMP sgRNA

    2:40pm
  • Addressing Process and Analytical Challenges with Orthogonal Purification and MS-guided PAT in the Manufacture of Synthetic Oligonucleotide Drug Substances (Oligo DS)

    4:15pm